Lixisenatide: Gastrointestinal : acute pancreatitis, hemorrhagic and necrotizing pancreatitis, ileus, intestinal obstruction, severe constipation including fecal impaction Hepatobiliary: cholecystitis, cholelithiasis requiring cholecystectomy Neurologic: dysgeusia, dysesthesia Pulmonary: pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists under-going elective surgeries or procedures requiring general anesthesia or deep sedation
Apply lowdose topical estrogen to improve vaginal tissue hydration and natural lubrication, especially after menopause
Product: Novo Nordisk's "Ecoinsulin Simaglutide Compound" has been approved for market in China On March 6, 2026, according to the official website of the State Food and Drug Administration, Novo Nordisk's Icosamesiglutide injection (lcoSema) was approved for marketing to treat type 2 diabetes
Learn More 901 S MoPac Expy, Building 1, Suite 300, Austin, TX 78746 101 Summit Ave, Suite 907, Fort Worth, TX 76102 17060 Dallas Parkway, Suite 112, Dallas, TX 75248 771 East Southlake Blvd, Suite 106, Southlake, TX 76092 650 Warrenville Road Suite 100 Lisle, IL 60532 Arizona Arkansas California Colorado Delaware Illinois Iowa Michigan Oklahoma Pennsylvania South Carolina Texas Utah Virginia Wisconsin 901 S MoPac Expy, Building 1, Suite 300, Austin, TX 78746 101 Summit Ave, Suite 907, Fort Worth, TX 76102 17060 Dallas Parkway, Suite 112, Dallas, TX 75248 771 East Southlake Blvd, Suite 106, Southlake, TX 76092 650 Warrenville Road Suite 100 Lisle, IL 60532 Arizona Arkansas California Colorado Delaware Illinois Iowa Michigan Oklahoma Pennsylvania South Carolina Texas Utah Virginia Wisconsin April 4, 2025 Table of Contents As the use of GLP-1 drugs rises, more people may seek help managing side effects and maintaining proper nutrition
